Altar Rock’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Altar Rock's TXG Position: Q3 2026 in Review
Altar Rock reduced its 10x Genomics (TXG) stake by 26% in Q3 2026, selling an estimated $161K and leaving 7,802 shares worth $629K. The position accounts for 0.96% of the portfolio, ranked #20.
Altar Rock first reported a position in TXG in Q4 2025 and has held it in 4 quarters since. 494 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Altar Rock held 7,802 shares of 10x Genomics worth $629K as of Q3 2026.
- Altar Rock sold 2,744 10x Genomics shares in Q3 2026, an estimated $161K.
- 10x Genomics made up 0.96% of Altar Rock's portfolio in Q3 2026, its #20 holding.
- Altar Rock first reported a position in 10x Genomics in Q4 2025 and has held it in 4 quarters since.
- 494 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Altar Rock's 13F filing for Q3 2026, filed 6 Nov 2026.